SEARCH

SEARCH BY CITATION

References

  • 1
    Verdecchia A, Francisci S, Brenner H et al. Recent cancer survival in Europe: a 2000–2002 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784796.
  • 2
    Tuinman MA, Hoekstra HJ, Sleijfer DT et al. Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy. Support Care Cancer 2007;15:279286.
  • 3
    Trask PC, Paterson AG, Fardig J, Smith DC. Course of distress and quality of life in testicular cancer patients before, during, and after chemotherapy: results of a pilot study. Psycho-Oncology 2003;12:814820.
  • 4
    Gurevich M, Devins GM, Rodin GM. Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics 2002;43:259281.
  • 5
    Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 2008;19:623629.
  • 6
    Jenkins V, Shilling V, Deutsch G et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006;94:828834.
  • 7
    Mehlsen M, Pedersen AD, Jensen AB, Zachariae R. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology 2008;18:248257.
  • 8
    Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 2006;98:17421745.
  • 9
    Stewart A, Collins B, Mackenzie J, Tomiak E, Verma S, Bielajew C. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. Psycho-Oncology 2008;17:122130.
  • 10
    Schagen SB, Boogerd W, Muller MJ et al. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol 2008;47:6370.
  • 11
    Pedersen AD, Rossen P, Mehlsen MY, Pedersen CG, Zachariae R, von der MH. Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc 2009;15:296301.
  • 12
    Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lonnqvist J. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 2008;106:127.
  • 13
    Chamberlain SR, Sahakian BJ. The neuropsychology of mood disorders. Curr Psychiatry Rep 2006;8:458463.
  • 14
    Cockburn J, Smith PT. Anxiety and errors of prospective memory among elderly people. Br J Psychol 1994;85(Pt 2):273282.
  • 15
    Waldstein SR, Ryan CM, Jennings JR, Muldoon MF, Manuck SB. Self-reported levels of anxiety do not predict neuropsychological performance in healthy men. Arch Clin Neuropsychol 1997;12:567574.
  • 16
    Hoffman R, Al'Absi M. The effect of acute stress on subsequent neuropsychological test performance (2003). Arch Clin Neuropsychol 2004;19:497506.
  • 17
    Cimprich B, So H, Ronis DL, Trask C. Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psycho-Oncology 2005;14:7078.
  • 18
    Ouimet LA, Stewart A, Collins B, Schindler D, Bielajew C. Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models. J Clin Exp Neuropsychol 2009;31:7389.
  • 19
    Nelson HE, Willison JR. The National Adult Reading Test—Test Manual (2nd edn). NFER-Nelson: Windsor, 1991.
  • 20
    Vaskinn A, Sundet K. Estimation of premorbid IQ: a Norwegian version of the National Adult Reading Test [Article in Norwegian]. Tidsskrift Norsk Psykologiforening 2001;38:11331140.
  • 21
    Peckham M. Testicular cancer. Acta Oncol 1988;27:439453.
  • 22
    Horowitz M, Wilner N, Alvarez W. Impact of event scale—measure of subjective stress. Psychosom Med 1979;41:209218.
  • 23
    Sundin EC, Horowitz MJ. Impact of event scale: psychometric properties. Br J Psychiatry 2002;180:205209.
  • 24
    Thewes B, Meiser B, Hickie IB. Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology 2001;10:459468.
  • 25
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361370.
  • 26
    Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:6977.
  • 27
    Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988;54:10631070.
  • 28
    Eysenck HJ, Eysenck SBG. Manual of the EPQ. Hodder and Stoughton: London, 1975.
  • 29
    Eysenck SBG, Tambs K. Cross-cultural comparison of personality: Norway and England. Scand J Psychol 1990;31:191197.
  • 30
    Ewing JA. Detecting alcoholism. The CAGE questionnaire. J Am Med Assoc 1984;252:19051907.
  • 31
    Aertgeerts B, Buntinx F, Kester A. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. J Clin Epidemiol 2004;57:3039.
  • 32
    Sahakian BJ, Owen AM. Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 1992;85:399402.
  • 33
    Levaux MN, Potvin S, Sepehry AA, Sablier J, Mendrek A, Stip E. Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. Eur Psychiatry 2007;22:104115.
  • 34
    Cambridge Cognition. CANTAB Eclipse Test Administration Guide. Cambridge Cognition Limited: Cambridge, UK, 2005.
  • 35
    Brandt J, Benedict R. Hopkins Verbal Learning Test—Revised. Professional manual. Psychological Assessment Resources, Inc.: Lutz, FL, 2001.
  • 36
    Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Theory and Clinical Interpretation (2nd edn). Neuropsychology Press: Tucson, AZ, 1993.
  • 37
    Delis DC, Kaplan E, Kramer JH, Ober BA. California Verbal Learning Test—Second Edition (CVLT II) Manual. Psychological Corporation: San Antonio, TX, 2000.
  • 38
    Ruff RM, Light RH, Parker SB, Levin HS. Benton controlled oral word association test: reliability and updated norms. Arch Clin Neuropsychol 1996;11:329338.
  • 39
    Mykletun A, Dahl AA, Haaland CF et al. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol 2005;23:30613068.
  • 40
    Fleer J, Sleijfer D, Hoekstra H, Tuinman M, Klip E, Hoekstra-Weebers J. Objective and subjective predictors of cancer-related stress symptoms in testicular cancer survivors. Patient Educ Couns 2006;64:142150.
  • 41
    van Basten JP, Jonker-Pool G, van Driel MF et al. Fantasies and facts of the testes. Br J Urol 1996;78:756762.